Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (94)	5/9/1998 2:06:00 PM
From: Boyce Burge	Read Replies (1) \| Respond to of 359

Similar thoughts occured to me. ABSC is mostly hardware (robotics, liquid handling) while INCY is mostly software. Which has higher margins, and which is quicker to market ?? -- I think we know the answers. If ABSC is also limited in the number of partners, then its in serious trouble with investors who thrive on announcements.

To: Richard Haugland who wrote (94)	5/16/1998 3:48:00 PM
From: Richard Haugland	Read Replies (1) \| Respond to of 359

ABSC Quarterly Report sec.yahoo.com Although the Company reported a small net income in 1997, the $3.7 million net loss in the first quarter of 1998 reflects the Company's expectation that substantial expenditures will be made in 1998 to accelerate the development of UHTSS technology. Accordingly, the Company does not expect to be profitable in 1998.